Crinetics Pharmaceuticals (CRNX) Change in Acquisitions & Divestments (2019 - 2026)

Crinetics Pharmaceuticals' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $302.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 1.17% year-over-year to $302.9 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 51.17% YoY), while the FY2025 annual figure was $1.2 billion, up 105.64% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $302.9 million, up from $271.2 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $382.4 million in Q3 2025, with the low at $11.7 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $101.4 million (2024), against an average of $150.4 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 28870.49% in 2022, while the deepest fall reached 66.66% in 2022.
• Crinetics Pharmaceuticals' Change in Acquisitions & Divestments stood at $70.7 million in 2022, then gained by 22.62% to $86.7 million in 2023, then surged by 112.24% to $184.0 million in 2024, then surged by 47.42% to $271.2 million in 2025, then gained by 11.68% to $302.9 million in 2026.
• Business Quant data shows CRNX's Change in Acquisitions & Divestments at $302.9 million in Q1 2026, $271.2 million in Q4 2025, and $382.4 million in Q3 2025.